Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Humanized anti-KSA monoclonal antibody - human interleukin-2 fusion protein

EU orphan designation number: EU/3/02/097
Active ingredient: Humanized anti-KSA monoclonal antibody - human interleukin-2 fusion protein
Indication: Treatment of renal cell carcinoma
Sponsor: Merck KGaA
Frankfurter Straße 250, 64293 Darmstadt, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/03/2002 Orphan designation EMEA/OD/063/01 (2002)1292 of 22/03/2002
28/03/2003 Removal of orphan designation from Community Register